PETALUMA, Calif., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS), today announced it will host its 2012 New York City Financial Analysts Presentation on November 28, 2012 from 11:30 am-1:00 pm ET. Moderated by Suraj Kalia, senior vice president of Northland Capital Markets, the presentation will include a panel discussion by medical experts of the current use of the Microcyn® Technology platform in both post-surgical settings and in the treatment of skin dermatoses, including atopic dermatitis. They will also share their perspectives on the potential impact of the Microcyn® Technology in both the surgical and acne markets once respective regulatory drug approvals are secured for those indications. Originally slated for earlier in the month, the analyst presentation was rescheduled to November 28 due to the impact of storm Sandy.